Description
RADIOPHARMACEUTICAL IDIQ CONTRACT FOR CLEVELAND
First action · last action
2016-10-01 · 2016-11-02
Transactions
3
First transaction's obligation
$496,403
Base + all options value (sum of deltas)
$3,304,609
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
5
SDVOSB flag on record
No
Parent IDV
VA25016D0053
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2016-10-01+$496,403= $496,403
- Mod P000012016-10-14+$24,167= $520,570
- Mod P000022016-11-02+$159,648= $680,218
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2016-10-01 | +$496,403 | $496,403 | RADIOPHARMACEUTICAL IDIQ CONTRACT FOR CLEVELAND |
| Mod P00001· FUNDING ONLY ACTION | 2016-10-14 | +$24,167 | $520,570 | RADIOPHARMACEUTICAL IDIQ CONTRACT FOR CLEVELAND |
| Mod P00002· FUNDING ONLY ACTION | 2016-11-02 | +$159,648 | $680,218 | RADIOPHARMACEUTICAL IDIQ CONTRACT FOR CLEVELAND |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI LSEHGNVLAVX5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026N0185 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $118,668 | FY2026 |
| 36C25026N0181 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $680,646 | FY2026 |
| 36C25026N0022 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $916,347 | FY2026 |
| 36C25025N0283 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $120,000 | FY2025 |
| 36C25025N0198 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $648,270 | FY2025 |
| 36C25025F0010 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $651,829 | FY2025 |
Other recipients under 6515 from 250-NETWORK CONTRACT OFFICE 10 (36C250) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25026F0700 | GOVERNMENT MARKETING AND PROCUREMENT, LLC | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $369,509 | FY2026 |
| 36C25026P1048 | DELTA INTERNATIONAL SERVICES & LOGISTICS (USA), INC | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $84,999 | FY2026 |
| 36C25026F0687 | PENTAX OF AMERICA, INC. | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $18,292 | FY2026 |
| 36C25026F0670 | A.M. COMMUNICATIONS SOLUTIONS, INC. | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $19,087 | FY2026 |
| 36C25026F0680 | OLYMPUS AMERICA INC | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $381,132 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25017J0002_3600_VA25016D0053_3600 · retrieved 2026-09-26.